Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of Texas MD Anderson Cancer Center

University of Texas MD Anderson Cancer Center in Houston, Texas, United States is listed as a site for 1,479 registered clinical trials, 230 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,479
Ongoing 230

This page covers the site record University of Texas MD Anderson Cancer Center in Houston, Texas, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the University of Texas MD Anderson Cancer Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,479 trials counted.

  • Phase 1 323 trials
  • Phase 1/2 146 trials
  • Phase 2 476 trials
  • Phase 2/3 17 trials
  • Phase 3 182 trials
  • Phase 4 14 trials
  • Not applicable 124 trials
  • Observational 193 trials
  • Expanded access 4 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 231 trials
  • Completed 934 trials
  • Terminated 225 trials
  • Other 89 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 81

1991: 1 trials (Phase 2 1) 1992: 1 trials (Phase 3 1) 1993: 3 trials (Phase 3 1, Phase 2 2) 1994: 11 trials (Observational 1, Phase 3 5, Phase 2 5) 1995: 14 trials (Observational 2, Phase 3 4, Phase 2 2, Phase 1/2 5, Phase 1 1) 1996: 16 trials (Phase 3 12, Phase 2 3, Phase 1 1) 1997: 26 trials (Not applicable 1, Phase 3 4, Phase 2 15, Phase 1/2 1, Phase 1 5) 1998: 51 trials (Not applicable 2, Phase 3 14, Phase 2 24, Phase 1/2 2, Phase 1 9) 1999: 54 trials (Observational 4, Not applicable 2, Phase 3 15, Phase 2 23, Phase 1/2 2, Phase 1 8) 2000: 45 trials (Observational 1, Not applicable 1, Phase 3 8, Phase 2/3 1, Phase 2 24, Phase 1/2 2, Phase 1 8) 2001: 49 trials (Observational 3, Not applicable 1, Phase 3 11, Phase 2/3 2, Phase 2 20, Phase 1/2 6, Phase 1 6) 2002: 39 trials (Observational 8, Not applicable 3, Phase 3 6, Phase 2 12, Phase 1/2 2, Phase 1 8) 2003: 40 trials (Observational 6, Phase 3 5, Phase 2 22, Phase 1/2 2, Phase 1 5) 2004: 26 trials (Observational 9, Not applicable 2, Phase 3 2, Phase 2 9, Phase 1/2 3, Phase 1 1) 2005: 39 trials (Observational 13, Not applicable 3, Phase 3 4, Phase 2/3 1, Phase 2 13, Phase 1/2 3, Phase 1 2) 2006: 54 trials (Observational 14, Not applicable 2, Phase 2 24, Phase 1/2 3, Phase 1 11) 2007: 65 trials (Observational 16, Not applicable 14, Phase 3 5, Phase 2/3 1, Phase 2 18, Phase 1/2 4, Phase 1 7) 2008: 62 trials (Observational 21, Not applicable 5, Phase 4 1, Phase 3 4, Phase 2 16, Phase 1/2 3, Phase 1 12) 2009: 64 trials (Observational 16, Not applicable 6, Phase 4 1, Phase 3 2, Phase 2 23, Phase 1/2 5, Phase 1 11) 2010: 66 trials (Observational 9, Not applicable 3, Phase 4 1, Phase 3 2, Phase 2 23, Phase 1/2 5, Phase 1 23) 2011: 81 trials (Observational 12, Not applicable 6, Phase 3 8, Phase 2/3 2, Phase 2 35, Phase 1/2 7, Phase 1 11) 2012: 77 trials (Observational 14, Not applicable 14, Phase 3 4, Phase 2 24, Phase 1/2 6, Phase 1 15) 2013: 65 trials (Observational 4, Not applicable 9, Phase 3 4, Phase 2 24, Phase 1/2 7, Phase 1 17) 2014: 59 trials (Observational 10, Not applicable 7, Phase 4 2, Phase 3 3, Phase 2/3 1, Phase 2 16, Phase 1/2 4, Phase 1 16) 2015: 78 trials (Observational 10, Not applicable 16, Phase 4 2, Phase 3 2, Phase 2 27, Phase 1/2 9, Phase 1 12) 2016: 68 trials (Observational 7, Not applicable 12, Phase 4 1, Phase 3 2, Phase 2/3 3, Phase 2 12, Phase 1/2 11, Phase 1 20) 2017: 56 trials (Observational 4, Not applicable 8, Phase 4 3, Phase 3 7, Phase 2 12, Phase 1/2 5, Phase 1 17) 2018: 36 trials (Observational 3, Not applicable 2, Phase 4 1, Phase 3 3, Phase 2 9, Phase 1/2 4, Phase 1 14) 2019: 36 trials (Observational 2, Phase 3 3, Phase 2/3 1, Phase 2 6, Phase 1/2 4, Phase 1 20) 2020: 28 trials (Phase 3 2, Phase 2 5, Phase 1/2 4, Phase 1 17) 2021: 37 trials (Observational 2, Phase 3 7, Phase 2 7, Phase 1/2 7, Phase 1 14) 2022: 32 trials (Observational 1, Not applicable 3, Phase 3 6, Phase 2/3 2, Phase 2 4, Phase 1/2 11, Phase 1 5) 2023: 33 trials (Phase 3 8, Phase 2 6, Phase 1/2 10, Phase 1 9) 2024: 18 trials (Not applicable 1, Phase 3 5, Phase 2 2, Phase 1/2 3, Phase 1 7) 2025: 25 trials (Not applicable 1, Phase 4 2, Phase 3 9, Phase 2/3 1, Phase 2 2, Phase 1/2 4, Phase 1 6)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 15
2025 25
2024 18
2023 33
2022 32
2021 37
2020 28
2019 36
2018 36
2017 56

Showing 10 of 36 years.

Start your 14-day trial Email me all 36 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,479 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 209 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 389 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF